Profile data is unavailable for this security.
About the company
Sino Medical Sciences Technology Inc is a China-based company mainly engaged in the research, development, production and sales of high-end interventional medical devices. The Company's product pipeline covers the field of interventional therapy such as cardiovascular, cerebrovascular, and structural heart disease. The Company's main products include coronary drug stent system and balloon dilatation catheters. The Company conducts its businesses within the domestic market and overseas markets, and it has subsidiaries in Beijing, China, Hong Kong, China, the United States, Japan, the Netherlands, and France.
- Revenue in CNY (TTM)361.15m
- Net income in CNY-20.92m
- Incorporated2007
- Employees652.00
- LocationSino Medical Sciences Technology Inc3F, Area A,TEDA Biomedical R&D Mansion, No. 5 FourTIANJIN 300457ChinaCHN
- Phone+86 1 082163261
- Fax+86 1 082162787
- Websitehttp://www.sinomed.com/
More ▼
Mergers & acquisitions
| Acquired company | 688108:SHH since announced | Transaction value |
|---|---|---|
| eLum Technologies Inc | -2.80% | 20.73m |
Data delayed at least 15 minutes, as of Jul 05 2024.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Well Lead Medical Co Ltd | 1.34bn | 190.64m | 3.12bn | 2.62k | 16.28 | 1.66 | -- | 2.34 | 0.6534 | 0.6534 | 4.57 | 6.42 | 0.5063 | 5.22 | 9.21 | 509,284.10 | 7.56 | 8.25 | 9.54 | 10.17 | 45.22 | 43.45 | 14.93 | 13.04 | 1.51 | -- | 0.2598 | 51.11 | 1.79 | 13.22 | 15.56 | 24.10 | 35.39 | 45.41 |
| TINAVI Medical Technologies Co Ltd | 199.48m | -175.09m | 3.21bn | 354.00 | -- | 2.60 | -- | 16.11 | -0.3862 | -0.3862 | 0.4396 | 2.75 | 0.1283 | 1.50 | 6.22 | 563,494.90 | -11.26 | -7.86 | -12.14 | -9.07 | 69.95 | 73.58 | -87.77 | -50.09 | 2.99 | -- | 0.156 | -- | 34.48 | 10.63 | -41.42 | -- | 51.87 | -- |
| Sino Medical Sciences Technology Inc | 361.15m | -20.92m | 3.54bn | 652.00 | -- | 4.28 | -- | 9.81 | -0.051 | -0.051 | 0.8809 | 2.00 | 0.3109 | 1.34 | 24.46 | 553,914.40 | -1.62 | -4.21 | -1.95 | -4.71 | 58.14 | 70.96 | -5.22 | -15.76 | 1.55 | -- | 0.1442 | -- | 77.99 | -2.04 | 75.59 | -- | -7.30 | -- |
| Hangzhou Alltest Biotech Co Ltd | 718.48m | 184.83m | 3.62bn | 1.09k | 19.64 | 0.925 | -- | 5.04 | 2.33 | 2.33 | 9.02 | 49.43 | 0.165 | 2.13 | 6.17 | 657,349.00 | 4.24 | 23.35 | 4.57 | 26.83 | 46.83 | 58.34 | 25.69 | 39.07 | 10.16 | -- | 0.0056 | 29.79 | -77.73 | 32.59 | -84.75 | 26.19 | 72.77 | -- |
| Getein Biotech Inc | 1.31bn | 244.26m | 3.81bn | 2.14k | 15.61 | 1.44 | -- | 2.92 | 0.4816 | 0.4816 | 2.58 | 5.22 | 0.3502 | 1.61 | 2.77 | 611,337.70 | 6.63 | 13.25 | 9.24 | 18.45 | 66.13 | 65.57 | 18.92 | 28.13 | 1.97 | -- | 0.1857 | 29.88 | -24.85 | 14.81 | -43.92 | 2.31 | 18.44 | 6.00 |
| SWS Hemodialysis Care Co Ltd | 659.16m | 154.15m | 3.83bn | 881.00 | 24.83 | 2.23 | -- | 5.81 | 0.7148 | 0.7148 | 3.06 | 7.97 | 0.3351 | 2.11 | 5.56 | 748,197.70 | 7.71 | -- | 8.68 | -- | 50.81 | -- | 23.00 | -- | 15.96 | -- | 0.0089 | -- | 80.65 | -- | 228.34 | -- | -- | -- |
| Hangzhou Ags Medtech Co Ltd | 529.86m | 235.79m | 3.88bn | 592.00 | 16.51 | 1.73 | -- | 7.33 | 2.91 | 2.91 | 6.54 | 27.80 | 0.3775 | 3.36 | 13.43 | 895,039.90 | 16.80 | -- | 17.73 | -- | 70.24 | -- | 44.50 | -- | 24.45 | -- | 0.0054 | -- | 37.09 | -- | 49.87 | -- | -- | -- |
| Jiangsu Bioperfectus Technologies Co Ltd | 400.25m | -314.32m | 4.04bn | 684.00 | -- | 1.17 | -- | 10.11 | -5.36 | -5.36 | 6.83 | 58.77 | 0.0915 | 0.8592 | 1.57 | 585,153.50 | -7.19 | 25.41 | -8.36 | 31.26 | 63.20 | 63.37 | -78.53 | 32.86 | 6.05 | -- | 0.086 | 30.54 | -92.72 | 11.81 | -120.45 | -- | 2.43 | -- |
| Shanghai Sanyou Medical Co Ltd | 385.98m | 58.83m | 4.05bn | 466.00 | 71.56 | 2.12 | -- | 10.51 | 0.228 | 0.228 | 1.53 | 7.71 | 0.1699 | 0.5891 | 2.20 | 828,288.80 | 3.29 | 9.42 | 3.86 | 10.85 | 71.52 | 87.15 | 19.34 | 29.78 | 3.35 | -- | 0.0291 | 16.21 | -29.08 | 15.67 | -49.91 | 8.99 | -15.60 | -- |
Data as of Jul 05 2024. Currency figures normalised to Sino Medical Sciences Technology Inc's reporting currency: Chinese Yuan Renminbi CNY
23.03%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Guotai Asset Management Co., Ltd.as of 31 Dec 2023 | 38.66m | 13.45% |
| Baoying Fund Management Co., Ltd.as of 31 Dec 2023 | 10.66m | 3.71% |
| Da Cheng Fund Management Co., Ltd.as of 31 Dec 2023 | 3.35m | 1.17% |
| Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 3.00m | 1.04% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 2.97m | 1.04% |
| JPMorgan Asset Management (China) Co Ltd.as of 31 Dec 2023 | 2.31m | 0.80% |
| New China Fund Management Co., Ltd.as of 31 Dec 2023 | 2.19m | 0.76% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 1.09m | 0.38% |
| Guolian Fund Management Co. Ltd.as of 31 Dec 2023 | 993.09k | 0.35% |
| Maxwealth Fund Management Co., Ltd.as of 31 Dec 2023 | 953.40k | 0.33% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
